Summary by Futu AI
On May 14, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], engaged in multiple transactions involving the company's common stock. Guyer executed the sale of 11,625 shares at a price of $12.649 per share, resulting in a total market value of $147,044.63. Prior to this sale, Guyer acquired 6,525 shares at $3.26 each and an additional 3,250 shares at $3.5 each through the exercise or conversion of derivative securities. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals totaled 5,550 shares of common stock.